infectious diseases case presentation 18 september 2002 dr zakeya bukhary, fellow, infectious...
TRANSCRIPT
![Page 1: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/1.jpg)
Infectious DiseasesCase Presentation
18 September 2002Dr Zakeya Bukhary, Fellow,
Infectious Diseases
Dr Hail Al-Abdely, Consultant, Infectious Diseases
![Page 2: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/2.jpg)
First Case
![Page 3: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/3.jpg)
• A 19-year-old girl from the Eastern Province, who was completely healthy until May 2001 when started to c/o:– RIF pain and fever associated with
constipation and weight loss– The pain was colicky and slowly progressive,
moderately severe, non-radiating and not relieved by analgesics
History
![Page 4: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/4.jpg)
History
• Fever was on and off with no diurnal variation and no night sweating or chills
• No nausea or vomiting
• No skin rash or joint pains
• Systemic review: unremarkable
![Page 5: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/5.jpg)
History
• No Hx of TB or contact with TB patients
• No previous abdominal surgeries• No drug Hx• Lives in Dhahran
![Page 6: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/6.jpg)
History
• At the local hospital (DHC), she was found to have ileocecal mass (5/2001)
• Colonoscopy showed ulcers of the Rt hemicolon and Bx was consistent with acute inflammation.
• Started empirically on ciprofloxacin + flagyl but without response
![Page 7: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/7.jpg)
History
• Colonic biopsy ? Crohn’s.
• Started on oral steroids.
• Has temporary improvement and gained wt.
• Oct 2001, f/u showed an increase in the mass size clinically and confirmed by CT abdomen.
![Page 8: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/8.jpg)
• 27 Oct 2001, laparatomy (at DHC) showed unresectable mass with intense inflammation involving the Rt. hemicolon
• Bx showed necrotizing granuloma with broad fungal hyphae. Culture was negative.
• Treated with ABLC and continued low dose steroid
• On 11 Nov 2002 referred to KFSH&RC for 2nd opinion
![Page 9: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/9.jpg)
• Pt was clinically unwell but not toxic
• P/E:
– T 38.8ºC PR 110/min BP 120/70RR 20 Wt 49 kg Ht 158 cm
– Not in distress or jaundiced or cyanosed
– Was pale
– No LN enlargement
– Chest/heart exam unremarkable
![Page 10: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/10.jpg)
Abd Exam
• Soft, with large, irregular, ill-defined mass extending from the RUQ to RIFand umbilical region; mildly tender and hard.
• Non-palpable liver or spleen• No ascitis• B.S. were present
![Page 11: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/11.jpg)
InvestigationWBC 14.0 PMN 80% No bands
Lymph 20.0%Eosinophils 1.3%
Hb 92 MCV 78.8 MCH 23.4Plt 305ESR 15Urea 4.9 Cr 96Na 135 K+ 3.3ALT 50 ALP 185 Bil 4 Alb30PPD skin test –ve CXR N
![Page 12: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/12.jpg)
CT abdomen
12 November 2001
![Page 13: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/13.jpg)
Differential Diagnosis
![Page 14: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/14.jpg)
D. Dx
• Deep GI mycosis
• TB
• Actinomycosis
• Crohn’s
• Lymphoma
![Page 15: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/15.jpg)
Course
• Review of histopath slides from DHC – showed moderate chronic colitis, no cryptitis with positive granuloma and fungal hyphae
• With prominent eosinophilic infiltrate
![Page 16: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/16.jpg)
Pathology
![Page 17: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/17.jpg)
• Pt was spiking high grade Temp 40.0º C
• Started on Ambisome + Tazocin for possibility of perforation and superadded bacterial infection
• Pain control, NPO, TPN
• Surgical opinion confirmed that the mass was non-operable
![Page 18: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/18.jpg)
• 14 Nov 2001– FNA and True cut Bx to get tissue for
microbiological Dx for c/s
• 17 Nov 2001– Steroids - methylprednisone 1 mg/kg/d started
Course
![Page 19: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/19.jpg)
• 20 Nov 2001– Dx of GI mycosis confirmed by culture positive
Basidiobolus ranarum– IV itraconazole was added– Ambisome changed to Ampho B to minimize
drug induced hepatitis
Course
![Page 20: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/20.jpg)
![Page 21: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/21.jpg)
• f/u CT scan Abd (20/11/2001):– showed very impressive response to steroids
+ antifungal (Ampho B + short course of itraconazole) with regression of the inflammation and dilatation of the Rt. hemicolon which has emptied its content and has partly collapsed.
Course
![Page 22: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/22.jpg)
• Clinically, pt was improving with no fever and no abd pain
• Started on oral feed
• 11 Dec 2001 discharged on ketoconazole 600 mg p.o. OD, and steroids on tapering dose
• In vitro - susceptibility test showed better inhibitory effect of ketoconazole which was started orally
![Page 23: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/23.jpg)
![Page 24: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/24.jpg)
CT abdomen
8/4/2002
2/9/2002
![Page 25: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/25.jpg)
Discussion
![Page 26: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/26.jpg)
Basidiobolomycosis
• Introduction
– Classification
– Epidemiology
– Pathogenesis & Clinical Manifestation
– Diagnosis
• Revision of invasive G.I.B.
• Rx
![Page 27: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/27.jpg)
Zygomycetes
Mucorales(Mucormycosis)
Entomophthorales(Entomophthoramycosis)
Conidiobolus Basidiobolus
![Page 28: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/28.jpg)
• Basidiobolus species are normal inhabitants of soil throughout the world
• They have been also isolated from the gut of amphibians and reptiles
![Page 29: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/29.jpg)
• These fungi cause a chronic inflammatory granulomatous disease (Entomophthoramycosis)
• reported in healthy inhabitants of tropical and subtropical regions (Africa, Southeast Asia, South America)
![Page 30: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/30.jpg)
• The mode of transmission of infection to humans remains unknown
• Inhalation, ingestion, direct inoculation and acquisition secondary to I.M. injection and insect bites have been postulated
![Page 31: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/31.jpg)
• The disease generally manifested as subcutaneous lesions
• Visceral involvement and deep invasive infection either primary or secondary to subcutaneous disease, is rare and affects mainly immunocompromised hosts and can be fatal.
Nazir et al, Ann Trop Paediatrics 1997;17:161
![Page 32: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/32.jpg)
• Diagnosis depends on microscopic documentation of tissue invasion and presence of typical hyphae of B. ranarum
• In contrast with mucormycosis no vascular invasion or tissue infarction or necrosis
![Page 33: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/33.jpg)
• Lesions produced by B. ranarum are characterized by an acute and/or chronic inflammation in association with broad, irregular, erratically septate hyphae, surrounded by a distinctive eosinophilic sheath
![Page 34: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/34.jpg)
• Culture of the fungus is the only way to identify correctly the species.
![Page 35: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/35.jpg)
• Immunodiffusion test has been used in several patients and claims 100% specificity specificity and may have a prognostic value.
Kaufman et al, J Clin Microb 1990;28:9:1887
![Page 36: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/36.jpg)
• The first case described of the infection was in a pt from Indonesia by Joe et al in 1956
• Approximately 300 cases (90% cutaneous) have been reported in the World Literature, mostly from Tropical Asia, Africa and South America
• A majority of cases have been in children under 10 years of age
![Page 37: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/37.jpg)
• In 1994, a healthy 8-year-old boy reported as a case of invasive retroperitoneal infection due to B. ranarum based on histopath who did not respond to high dose Ampho B but the mass resolved completely in 6/52 in response to K1 saturated solution orally
Ann Trop Paediatrics 1997;17:161
![Page 38: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/38.jpg)
![Page 39: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/39.jpg)
• The 5th case was a 49-year-old lady who presented with GIB mimicking Crohn’s disease with no response to mesalamine and steroids
• Diagnosed histopathologically
• Responded clinically to oral itraconazole
Smilack et al, Gastroenterology 1997;119:250
![Page 40: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/40.jpg)
• In 1996 B. ranarum involving the rectum was reported from Kuwait, in a 30-year-old man presented with PR-bleed and polypoid mass
• Dx confirmed by culture
• Responded to antifungals (Ampho B + ketoconazole)
Khan et al CID 1998;26:521
![Page 41: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/41.jpg)
Am J Clin Pathol 1999;112:610
![Page 42: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/42.jpg)
• Lyon et al conducted a case-control study to generate hypotheses about potential risk factors in the reported few cases of GIB in AZ, between 1994 to 1999.
• According to their results they considered:–Ranitidine–Smoking–Digging earth as of one’s job
![Page 43: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/43.jpg)
• The length of residence in AZ to be associated significantly with GIB
![Page 44: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/44.jpg)
• Some factors did not reach statistical significance, including:
–Steroids
–Use of over-the-counter drugs
–Animal contact
–Eating unwashed vegetables
• One of the cases had a Hx of PICA daily for years before the Dx of GIB
CID 2001;32:1448
![Page 45: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/45.jpg)
• Currently, there is no means of preventing this infection or even identifying those at risk for development of this disease
• Early detection of the disease seems to be the best hope of reducing the serious morbidity and mortality associated with long-standing disease
![Page 46: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/46.jpg)
• Based on the limited information, it appears that optional treatment of GIB combines surgical and medical methods
• Pts should undergo resection and debridement of all affected tissues; followed prolonged antifungal Rx
CID 2001;32;1448
![Page 47: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/47.jpg)
• Clinical failures have been described in association with Ampho B
Mycopathologia 1986;95:101Am Trop Paed 1997;17:161CID 1999;28:1244
![Page 48: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/48.jpg)
• Ketoconazole has been shown to be effective in both in vitro and in vivo studies
AAC 1984;25:413
![Page 49: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/49.jpg)
• The best choice of antifungal agent is not clear, but itraconazole seems to have the best results
Mycopathologia 1986;95:101Am J Kidney Dis 1997;29:620Am J Clin Pathol 1999;112:610CID 1998;27:663CID 1999;28:1244CID 2001;32:1448
![Page 50: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/50.jpg)
• In general Basidiobolus spp displays low MICs of itraconazole 0.25 g/ml, ketoconazole 0.5 g/ml
• MICs of 0.1 – 1.0 g/ml found to be inhibitory
JAC 1999;44:557
Rev Inf Dis 1987;9(Suppl 1):S15
![Page 51: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/51.jpg)
End of First Case
![Page 52: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/52.jpg)
Second CaseSecond Case
![Page 53: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/53.jpg)
History
• 52Y/O American white female.– Told to have pulmonary nodules on CXR
10/9/01and subsequently on CT chest 21/9/01 in the US.
– Totally asymptomatic.– No Intervention– Moved to Saudi Arabia with her husband
(work for a Saudi bank) 11/2001
![Page 54: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/54.jpg)
History
• Lived in: – Arkansas- childhood– California (1978-1995)– Scotland (1995-1998)– Poland (1998-2001)
![Page 55: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/55.jpg)
History
• PMH:– Hypertension– Hyperlipidemia– S/P Hysterectomy & salpingo-opherectomy
1996 for large ovarian cyst.
![Page 56: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/56.jpg)
Meds
• Quinapril 20mg QD
• Indapamide 1.5mg QD
• Simvastatin 40mg QD
![Page 57: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/57.jpg)
History
• Seen in a private hospital in Riyadh– Clinical evaluation was unremarkable– PPD: negative – CT chest 17/1/02
![Page 58: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/58.jpg)
17/1/2002
![Page 59: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/59.jpg)
17/1/2002
![Page 60: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/60.jpg)
17/1/2002
![Page 61: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/61.jpg)
17/1/2002
![Page 62: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/62.jpg)
Differential Diagnosis
What will you do next?
![Page 63: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/63.jpg)
Intervention
• Open-Lung biopsy 6/2/02– Report
• “Caseating granuloma”.• Sent for TB culture.
Start 4 drugs anti TB (4 March 2002)High fever and diffuse skin rash (12 March 2002)
Stop anti TB Better
![Page 64: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/64.jpg)
Course
• 20 March 2002– Further stains showed fungus– Started on fluconazole 400mg QD
– Serologies sent for:• Cryptococcal serum antigen, negative• Coccidioides ab, negative• Balstomyces ab, negative• Histoplasma ab, could not be determined
![Page 65: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/65.jpg)
Pathology
![Page 66: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/66.jpg)
11/6/2002
![Page 67: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/67.jpg)
11/6/2002
![Page 68: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/68.jpg)
• D/C fluconazole and start itraconazole 400 mg QD
• Patient did not take it.
![Page 69: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/69.jpg)
28/8/2002
![Page 70: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/70.jpg)
28/8/2002
![Page 71: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/71.jpg)
Histoplasmosis
• Introduction
–Pathogenesis
–C. Fx
–Dx
–Rx
![Page 72: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/72.jpg)
Histoplasmosis
• Histoplasma capsulatum was first described in 1905.
• It is a thermally dimorphic fungus, found in soil enriched by droppings of some birds and bats
• It can remain viable for years in the soil
![Page 73: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/73.jpg)
Histoplasma capsulatum (filamentous phase)
![Page 74: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/74.jpg)
![Page 75: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/75.jpg)
Pathogenesis
• Hyphal elements of H. capsulatum, are inhaled into the lungs, where they reach the alveolar spaces and transform into yeasts forms
• Following pulmonary infection, organisms spread through lymphatics to the regional lymph nodes and hematogenously to other organs
![Page 76: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/76.jpg)
• In immunocompetent patients resemble tuberculosis, with caseating granulomas and necrosis
• Granulomas heal with fibrosis and can calcify
• Reactive arthritis, pericarditis and erythema nodosum can present
![Page 77: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/77.jpg)
Clinical
• The degree of exposure and immune status of the host determines the severity of the disease
• More than 95% of persons infected are asymptomatic
• Histoplasmoma: a coin-like lesion in the lungs
![Page 78: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/78.jpg)
• In symptomatic cases:– Primary pulmonary histoplasmosis
• Mild self-limiting disease• Rarely severe with ARDS
– Chronic pulmonary histoplasmosis• Occurs in a setting of underlying
disease, e.g. COPD• Subacute recurrent pneumonia• Associated with apical fibrosis and
cavitation
![Page 79: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/79.jpg)
• In symptomatic cases (cont.):
–Disseminated disease
• Most serious form, usually in immunodeficient patients with prolonged fever, hepatosplenomegaly, meningoencephalitis, sepsis, DIC.
![Page 80: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/80.jpg)
Dx
• Tissue Bx stains are highly sensitive
• Immunodiffusion (more specific less
sensitive ) and complement fixation (more sensitive less specific) antibody tests assist in Dx
![Page 81: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/81.jpg)
• Antigen detection by radioimmunoassays in serum and urine is highly sensitive and specific in disseminated disease
• In patients with AIDS who have disseminated histoplasmosis, elevated antigen levels are present in the urine in 95% of cases, and in the serum in 80%.
![Page 82: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/82.jpg)
Therapy
• In immunocompetent patients: itraconazole is the drug of choice and it is highly effective
• Ampho B has a response rate of more than 75% in meningeal and life-threatening histoplasmosis
Dismukes et al, Am J Med 1992;93:489
![Page 83: Infectious Diseases Case Presentation 18 September 2002 Dr Zakeya Bukhary, Fellow, Infectious Diseases Dr Hail Al-Abdely, Consultant, Infectious Diseases](https://reader036.vdocuments.us/reader036/viewer/2022062313/56649c945503460f9495080f/html5/thumbnails/83.jpg)